- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04064281
The Healthy Cantonese Diet on Cardiometabolic Syndrome
August 19, 2019 updated by: Huilian Zhu, Sun Yat-sen University
Effect of the Healthy Cantonese Diet on Cardiometabolic Syndrome in Chinese Adults
The DASH diet (Dietary Approaches to Stop Hypertension) have been proven to lower risk of cardiovascular diseases.
But the DASH diet is inconsistent with Chinese dietary pattern.
In this study, based on the typical Cantonese diet, the healthy Cantonese diet is developed according to the DASH diet and the balanced dietary pattern of the Chinese Dietary Guidelines 2016.
The randomized control trial is designed to investigate whether the healthy Cantonese diet has benefit to blood pressure, blood lipid, blood glucose and other cardiometabolic biomarkers among adults with cardiometabolic syndrome in Guangdong, China.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 25-75 years old, male or female;
- have lived in this community for the past six months, and have no plans to move out or go out in the next three months;
- the systolic blood pressure is within 130-159mmHg regardless of medication.
- maintaining the current medication (mainly drugs for hypertension, diabetes or hyperlipidemia) throughout the research period, with the category and dose unchanged;
- the number of test meal consumed is no less than 18;
- community feeding mode: eat a meal at least once a day at the research center (preferably lunch or dinner); or home delivery mode: upload meal pictures for three meals every day, and eat a meal and have physical examination at the research center at least once a week;
- sign the informed consent form.
Exclusion Criteria:
- fasting blood glucose ≥10.0mmol/L;
- total cholesterol ≥7.2mmol/L;
- injected inulin within a month;
- unwilling or unable to change the original dietary pattern, or have special dietary needs (such as vegetarians);
- alcoholism;
- BMI ≥30kg/m^2, or losing weight currently;
- have acute cardiovascular and cerebrovascular events occurred in the past six months;
- have a history of chronic kidney disease, intestinal irritation or asthma;
- women who have been/are preparing for pregnancy or lactation;
- in combination with other serious diseases such as cancer, chronic heart failure, severe depression or other mental disorders, long-term bedridden or unable to move freely;
- have a history of common food allergies (eggs, seafood, peanuts, etc.);
- have undergone gastrointestinal surgery;
- currently suffering from acute phase of diseases such as respiratory infections, fever, severe diarrhea;
- have deaf-mutism, dementia, unable to communicate properly.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: the healthy Cantonese diet
Based on the typical Cantonese diet, the healthy Cantonese diet is developed according to the DASH diet and the balanced dietary pattern of the Chinese Dietary Guidelines 2016.
In this diet, the main nutrients, dietary fiber, sodium, calcium, magnesium and potassium are set to achieve the healthy goal.
Compared with the typical Cantonese diet, the healthy Cantonese diet is increased in fruit, vegetables, low-fat dairy products, whole grains, nuts and seeds, and reduced in salt, oil and sweets.
|
After a 1-week run-in period, the intervention group will eat the healthy Cantonese diet for 4 consecutive weeks.
Free meals will be provided 3 times a day (breakfast, lunch, dinner).
The actually intake of every meal for all subjects will be recorded to estimate their nutrients intake.
All subjects will be advised to avoid eating other food, but they should inform researchers of what they eat if they eat food that we will not provide.
|
|
Placebo Comparator: the typical Cantonese diet
The typical Cantonese diet is a diet of what many Cantonese eat.
In this diet, the main nutrients, dietary fiber, sodium, calcium, magnesium and potassium are set at the average dietary intake levels in Guangdong.
|
After a 1-week run-in period, the control group will still eat the typical Cantonese diet for 4 consecutive weeks.
Free meals will be provided 3 times a day (breakfast, lunch, dinner).
The actually intake of every meal for all subjects will be recorded to estimate their nutrients intake.
All subjects will be advised to avoid eating other food, but they should inform researchers of what they eat if they eat food that we will not provide.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Metabolic syndrome score
Time Frame: before and after 4-week intervention
|
Changes of metabolic syndrome score in healthy Cantonese diet compared with changes of typical Cantonese diet.
Metabolic syndrome score will be derived by standardizing and then summing the following continuously distributed indices of adiposity (waist circumference) to create a z score: hypertension (the average of systolic blood pressure and diastolic blood pressure); hyperglycaemia (fasting plasma glucose); insulin resistance (fasting insulin); fasting HDL-cholesterol × -1; and fasting triacylglycerol z score.
|
before and after 4-week intervention
|
|
Systolic blood pressure and diastolic blood pressure
Time Frame: before and after 4-week intervention
|
Changes of systolic blood pressure and diastolic blood pressure in healthy Cantonese diet compared with changes of typical Cantonese diet.
Blood pressure will be measured by trained investigator at baseline, week 1, week 2, week 3 and week 4, and systolic blood pressure and diastolic blood pressure will be recorded.
|
before and after 4-week intervention
|
|
Blood lipid profile
Time Frame: before and after 4-week intervention
|
Changes of blood lipid profile in healthy Cantonese diet compared with changes of typical Cantonese diet.
Blood lipid profile (total cholesterol, TC; triglyceride, TG; LDL cholesterol, LDLc; HDL cholesterol, HDLc) will be tested by a validated biomedical analyses laboratory using vein serum at baseline and week 4.
|
before and after 4-week intervention
|
|
Glucose metabolism
Time Frame: before and after 4-week intervention
|
Changes of glucose metabolism in healthy Cantonese diet compared with changes of typical Cantonese diet.
Glucose metabolism (fasting plasma glucose and fasting insulin) will be tested by a validated biomedical analyses laboratory using vein serum at baseline and week 4 and insulin resistance index (HOMA-IR) will be calculated by [fasting insulin (mU/L) × fasting plasma glucose (mmol/L) ]/22.5.
|
before and after 4-week intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood biochemical marker
Time Frame: before and after 4-week intervention
|
Changes of blood biochemical marker in healthy Cantonese diet compared with changes of typical Cantonese diet.
Blood biochemical marker (calcium, potassium, sodium, magnesium and phosphorus in mmol/L; uric acid in μmol/L) will be tested by a validated biomedical analyses laboratory using vein serum at baseline and week 4.
|
before and after 4-week intervention
|
|
Urinary sodium and potassium
Time Frame: before and after 4-week intervention
|
Changes of urinary sodium and potassium in healthy Cantonese diet compared with changes of typical Cantonese diet.
Urinary sodium and potassium will be tested by a validated biomedical analyses laboratory using morning urine at baseline and week 4.
|
before and after 4-week intervention
|
|
Intestinal microbiota composition
Time Frame: before and after 4-week intervention
|
Changes of intestinal microbiota composition in healthy Cantonese diet compared with changes of typical Cantonese diet.
|
before and after 4-week intervention
|
|
Gut microbial gene richness
Time Frame: before and after 4-week intervention
|
Changes of gut microbial gene richness in healthy Cantonese diet compared with changes of typical Cantonese diet.
|
before and after 4-week intervention
|
|
Inflammatory biomarkers
Time Frame: before and after 4-week intervention
|
Changes of inflammatory biomarkers in healthy Cantonese diet compared with changes of typical Cantonese diet.
Inflammatory biomarkers (CRP in mg/L; Tumor TNF-α and IL-6 in ng/L) will be tested by a validated biomedical analyses laboratory using vein serum at baseline and week 4.
|
before and after 4-week intervention
|
|
Cardiopulmonary function
Time Frame: before and after 4-week intervention
|
Changes of cardiopulmonary function in healthy Cantonese diet compared with changes of typical Cantonese diet.
Cardiopulmonary function will be measured by cardiopulmonary exercise testing using CORTEX MetaLyzer 3B at baseline and week 4.
|
before and after 4-week intervention
|
|
Endothelial function
Time Frame: before and after 4-week intervention
|
Changes of endothelial function in healthy Cantonese diet compared with changes of typical Cantonese diet.
Flow-mediated dilatation (FMD) will be assessed to evaluate endothelial function by using UNEX EF38G at baseline and week 4.
|
before and after 4-week intervention
|
|
Body composition
Time Frame: before and after 4-week intervention
|
Changes of body composition in healthy Cantonese diet compared with changes of typical Cantonese diet.
Body composition will be tested by using dual energy X-ray absorptiometry at baseline and week 4.
|
before and after 4-week intervention
|
|
Body mass index (BMI)
Time Frame: before and after 4-week intervention
|
Height in meters and weight in kilograms will be combined to report body mass index (BMI) in kg/m^2.
|
before and after 4-week intervention
|
|
Ratio of waist to hip circumference (WHR)
Time Frame: before and after 4-week intervention
|
Waist circumference in centimeters and hip circumference in centimeters will be combined to report ratio of waist to hip circumference (WHR).
|
before and after 4-week intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2019
Primary Completion (Anticipated)
December 31, 2021
Study Completion (Anticipated)
December 31, 2022
Study Registration Dates
First Submitted
August 12, 2019
First Submitted That Met QC Criteria
August 19, 2019
First Posted (Actual)
August 21, 2019
Study Record Updates
Last Update Posted (Actual)
August 21, 2019
Last Update Submitted That Met QC Criteria
August 19, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CC-2019-03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperglycemia
-
Mayo ClinicCompletedHospital Hyperglycemia | Post-transplant HyperglycemiaUnited States
-
Zealand University HospitalNot yet recruitingStress Hyperglycemia | Postoperative Hyperglycemia
-
University of CopenhagenUnknownSurgery--Complications | Hyperglycemia Stress | Hyperglycemia Steroid-inducedDenmark
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
Zealand University HospitalRecruitingAnesthesia | Surgical Procedure, Unspecified | Hyperglycemia Stress | Continuous Glucose Monitoring | Hyperglycemia Steroid-inducedDenmark
-
Harokopio UniversityNational and Kapodistrian University of AthensCompleted
-
University of SharjahCompletedPostprandial HyperglycemiaUnited Arab Emirates
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal
-
University of BergenCompleted
-
Franklin Pierce UniversityTerminatedHyperglycemia, PostprandialUnited States
Clinical Trials on the healthy Cantonese diet
-
University of HawaiiNational Cancer Institute (NCI); National Institutes of Health (NIH); University...Suspended
-
Diakonhjemmet HospitalAarhus University Hospital; University Hospital, UmeåRecruitingRheumatoid Arthritis | Psoriatic Arthritis | SpondyloarthritisNorway
-
Johns Hopkins UniversityCompleted
-
University College, LondonUniversity College London HospitalsCompletedObesity | Overweight | Cardiometabolic SyndromeUnited Kingdom
-
National Cattlemen's Beef Association, a contractor...Nutrasource Pharmaceutical and Nutraceutical Services, Inc.RecruitingInflammation | Pre-Diabetes | Metabolic Syndrome (MetS)Canada
-
Laval UniversityCompletedFamilial Hypercholesterolemia | Cholesterol, Elevated | Nutrition, HealthyCanada
-
Karolinska InstitutetNot yet recruitingHyperkalemia | Chronic Kidney Disease (Stages 4 and 5)Sweden
-
Örebro University, SwedenHorizon 2020 - European CommissionCompletedMetabolic Syndrome | Healthy Aging | Diet, HealthySweden
-
Cairo UniversityYasmin Mohamed AssimCompleted
-
Chalmers University of TechnologyUniversity of Oslo; University of Copenhagen; University College Dublin; German... and other collaboratorsRecruitingMetabolic ControlNetherlands, Norway, Sweden